Why the study?
Newly diagnosed AF associated with acute STEMI holds significant clinical relevance, prompting evaluation of the monocyte to HDL-C ratio for predicting its occurrence.
Does the monocyte-to-HDL-cholesterol ratio predict new-onset atrial fibrillation in patients with acute STEMI?
Does the monocyte-to-HDL-cholesterol ratio predict new-onset atrial fibrillation in patients with acute STEMI?
An increased monocyte-to-HDL-cholesterol ratio may serve as a simple, easily assessed predictor for new-onset atrial fibrillation in patients undergoing primary PCI for acute STEMI.
Answers are grounded in this paper and cite their sources.
May warrant monitoring in high-MHR STEMI patients; leaves open incremental value and need for prospective validation.
OBJECTIVE: Newly diagnosed AF (NOAF) associated with acute STEMI holds significant relevance in clinical practice. This study seeks to assess the role of the monocyte to HDL-C ratio (MHR) in predicting NOAF in these patients. METHODS: Between July 2017 and May 2018, 663 patients who underwent primary PCI for STEMI were retrospectively analyzed. NOAF was identified in 34 patients (5.1%), and this group was compared with those without AF. CONCLUSION: The present study revealed that increased MHR robust indicator for NOAF in STEMI patients and can be easily assessed in clinical practice. Incorporating MHR alongside established traditional risk factors may enhance the identification of patients at risk for AF in those with STEMI.
No takes yet. Share an insight, caveat, or question.
Tanık et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: